Small Canadian firm hopeful for U.S. flu vaccine contract next year

02/23/2005 | Reuters

ID Biomedical may not be able to sell its flu vaccine to the U.S. in time for the current season or for the 2005-2006 season, but CEO Tony Holler said he is optimistic the firm will get approval to supply Fluviral for the 2006-2007 flu season. The FDA still needs to inspect the company's facilities and approve its proposals for clinical trials for its vaccine.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX